DiaMedica Therapeutics Inc. logo

DiaMedica Therapeutics Inc.

DMAC | NASDAQ
Chart Builder DCF Calculator
$7.26
+$0.41 (+5.99%)
At close: Sep 21, 2026, 4:00 PM ET
$7.26
$0 (0.00%)
After-hours: Sep 21, 2026, 4:10 PM ET
Fiscal Quarter
Period Ending
Q2 2026
Jun 29, 2026
Q1 2026
Mar 30, 2026
Q4 2025
Dec 30, 2025
Q3 2025
Sep 29, 2025
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024
Q2 2024
Jun 29, 2024
Q1 2024
Mar 30, 2024
Q4 2023
Dec 30, 2023
Q3 2023
Sep 29, 2023
Q2 2023
Jun 29, 2023
Q1 2023
Mar 30, 2023
Q4 2022
Dec 30, 2022
Q3 2022
Sep 29, 2022
Q2 2022
Jun 29, 2022
Q1 2022
Mar 30, 2022
Q4 2021
Dec 30, 2021
Q3 2021
Sep 29, 2021
Q2 2021
Jun 29, 2021
Q1 2021
Mar 30, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-10.13M -10.48M -9.21M -9.03M -8.01M -8.14M -8.42M -6.88M -5.64M -5.74M -5.85M -5.16M -4.74M -5.52M -3.97M -3.13M -3.36M -3.54M -3.25M -3.42M -3.37M -3.62M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 353K n/a n/a 35K n/a n/a n/a 4K
Pretax Income
-10.13M -10.04M -8.73M -8.61M -7.69M -7.7M -7.89M -6.27M -5.11M -5.14M -5.14M -4.46M -4.47M -5.27M -3.74M -3.05M -3.35M -3.5M -3.24M -3.44M -3.27M -3.62M
Net Income
-10.14M -10.04M -8.74M -8.62M -7.7M -7.71M -7.9M -6.27M -5.12M -5.15M -5.16M -4.47M -4.48M -5.27M -3.75M -3.06M -3.36M -3.51M -3.25M -3.45M -3.27M -3.62M
Selling & General & Admin
2.35M 2.5M 2.51M 2.6M 2.19M 2.49M 1.95M 1.9M 1.71M 2.07M 2.17M 1.89M 2.2M 1.9M 1.7M 1.49M 1.41M 1.56M 1.38M 1.08M 1.21M 1.21M
Research & Development
8.15M 7.99M 6.7M 6.44M 5.82M 5.66M 6.47M 4.98M 3.93M 3.68M 3.68M 3.27M 2.54M 3.62M 2.27M 1.64M 1.96M 1.97M 1.87M 2.33M 2.16M 2.41M
Other Expenses
-366K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
10.13M 10.48M 9.21M 9.03M 8.01M 8.14M 8.42M 6.88M 5.64M 5.74M 5.85M 5.16M 4.74M 5.52M 3.97M 3.13M 3.36M 3.54M 3.25M 3.42M 3.37M 3.62M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 159K n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
10.13M 10.48M 9.21M 9.03M 8.01M 8.14M 8.42M 6.88M 5.64M 5.74M 5.85M 5.16M 4.74M 5.52M 3.97M 3.13M 3.36M 3.54M 3.25M 3.42M 3.37M 3.62M
Income Tax Expense
7K -7K 10K 6K 6K 6K 9K 7K 7K 7K 22K 7K 7K 7K 7K 7K 7K 7K 7K 7K 7K 7K
Shares Outstanding (Basic)
53.89M 53.79M 46.98M 49.63M 42.96M 42.84M 42.82M 42.75M 38.07M 37.96M 37.96M 37.95M 27.31M 26.45M 26.44M 26.44M 26.44M 26.44M 19.04M 19.04M 18.79M 18.77M
Shares Outstanding (Diluted)
53.89M 53.79M 46.98M 49.63M 42.96M 42.84M 42.82M 42.75M 38.07M 37.96M 37.96M 37.95M 27.31M 26.45M 26.44M 26.44M 26.44M 26.44M 19.04M 19.04M 18.79M 18.77M
EPS (Basic)
-0.19 -0.19 -0.17 -0.17 -0.18 -0.18 -0.18 -0.15 -0.13 -0.14 -0.14 -0.12 -0.16 -0.20 -0.14 -0.12 -0.13 -0.13 -0.17 -0.18 -0.17 -0.19
EPS (Diluted)
-0.19 -0.19 -0.17 -0.17 -0.18 -0.18 -0.18 -0.15 -0.13 -0.14 -0.14 -0.12 -0.16 -0.20 -0.14 -0.12 -0.13 -0.13 -0.17 -0.18 -0.17 -0.19
EBITDA
-9.75M -10.02M -8.72M -8.6M -7.69M -7.69M -7.88M -6.26M -5.1M -5.14M -5.13M -4.46M -4.46M -5.26M -3.58M -3.05M -3.35M -3.5M -3.23M -3.44M -3.26M -3.61M
EBIT
-10.13M -10.04M -8.73M -8.61M -7.69M -7.7M -7.89M -6.27M -5.11M -5.14M -5.14M -4.46M -4.47M -5.27M -3.59M -3.05M -3.35M -3.5M -3.24M -3.44M -3.27M -3.62M
Depreciation & Amortization
382K 11K 11K 18K 3K 11K 11K 10K 10K 8K 8K 8K 7K 7K 6K 7K 6K 6K 6K 6K 6K 6K

© 2026 bestshares.com. All rights reserved.